Pharmacy News Articles

▼ Show details

MDLinx Pharmacy helps physicians and healthcare professionals stay up to date with the latest pharmacy news articles and research, as well as pharmacy jobs, conferences, and resources.

Ranked, sorted, and summarized by MDLinx editors from the latest literature

1 Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: Results of a randomized, placebo-controlled phase III trial Journal of Clinical Oncology, September 22, 2014    Clinical Article

2 Open Flow Microperfusion: Pharmacokinetics of human insulin and insulin detemir in the interstitial fluid of subcutaneous adipose tissue Diabetes, Obesity and Metabolism, September 22, 2014    Clinical Article

3 Cost-effectiveness of salmeterol/fluticasone propionate combination (Advair) in uncontrolled asthma in Canada Respiratory Medicine, September 22, 2014    Clinical Article

4 A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism American Journal of Transplantation, September 22, 2014    Clinical Article

5 Oritavancin: first global approval Drugs, September 22, 2014    Review Article

6 Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date Full Text Drug Design, Development and Therapy, September 22, 2014    Review Article

7 Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: A systematic review and meta-analysis International Journal of Infectious Diseases, September 22, 2014    Evidence Based Medicine    Review Article

8 Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions European Journal of Clinical Pharmacology, September 22, 2014    Clinical Article

9 Study showed AstraZeneca’s exenatide once-weekly suspension for autoinjection provided superior HbA1c reductions vs. twice-daily exenatide (Byetta) in adults with type 2 diabetes Full Text AstraZeneca, September 22, 2014

10 Dupilumab: a novel treatment for asthma Full Text Journal of Asthma and Allergy, September 22, 2014    Review Article

11 Randomized trial comparing the effects of a low-dose combination of nifedipine GITS and valsartan versus high-dose monotherapy on central hemodynamics in patients with inadequately controlled hypertension: FOCUS study Blood Pressure Monitoring, September 22, 2014    Clinical Article

12 Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma Neuro-Oncology, September 22, 2014    Clinical Article

13 Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: A randomized, open-label study Full Text PLoS Neglected Tropical Diseases, September 22, 2014    Clinical Article

14 Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention Journal of Interventional Cardiology, September 22, 2014    Clinical Article

15 Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05% Eye & Contact Lens: Science and Clinical Practice, September 22, 2014    Clinical Article

16 Statin use in Australian children: a retrospective audit of four pediatric hospitals Pediatric Drugs, September 22, 2014    Clinical Article

17 A systematic review of calcium channel blocker use and cognitive decline/dementia in the elderly Journal of Hypertension, September 22, 2014    Clinical Article

18 Targeting the modulation of neural circuitry for the treatment of anxiety disorders Pharmacological Reviews, September 22, 2014    Review Article

19 Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy? Drugs, September 22, 2014    Clinical Article

20 Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells Full Text Molecular Cancer, September 22, 2014    Review Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Other Topics in Pharmacy

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More